Menu
Medical Condition
Urology & Andrology
Urology & Andrology ICD-10: N48.3

Ischemic (Low-Flow) Priapism

Clinical Criteria for Ischemic (Low-Flow) Priapism.

Medical Disclaimer
This condition guide is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding any symptoms or medical conditions.

Clinical Assessment & Protocol

Typical Presentation (HPI)

EN: Patient presents with a persistent, painful penile erection lasting [X] hours. Denies recent trauma to the perineum or genitalia. Reports [no/yes] history of sickle cell disease, hematologic malignancy, or use of intracavernosal injection therapy/PDE5 inhibitors. Pain is described as [mild/moderate/severe] and progressive. AR: يعاني المريض من انتصاب مؤلم ومستمر للقضيب منذ [X] ساعة. ينفي المريض وجود إصابة حديثة في العجان أو الأعضاء التناسلية. لا يوجد/يوجد تاريخ مرضي لفقر الدم المنجلي، أو الأورام الدموية، أو استخدام حقن داخل الجسم الكهفي أو مثبطات إنزيم فوسفودايستريز-5. الألم يوصف بأنه [خفيف/متوسط/شديد] ومتزايد.

General Examination

EN: Physical exam reveals a rigid, tender corpora cavernosa with a soft, flaccid glans penis. Penile shaft is extremely tender to palpation. No evidence of perineal hematoma or trauma. Vital signs are stable. Cavernosal blood gas analysis (if performed) demonstrates: pH [value], pO2 [value], pCO2 [value], consistent with severe hypoxia, hypercapnia, and acidosis. AR: يكشف الفحص السريري عن صلابة وإيلام في الجسمين الكهفيين مع ليونة في حشفة القضيب. يوجد إيلام شديد عند جس جسم القضيب. لا توجد علامات لوجود ورم دموي أو إصابة في العجان. العلامات الحيوية مستقرة. تحليل غازات الدم الكهفي (في حال إجرائه) يظهر: درجة الحموضة [القيمة]، ضغط الأكسجين [القيمة]، ضغط ثاني أكسيد الكربون [القيمة]، مما يتوافق مع نقص الأكسجة الشديد، وفرط ثاني أكسيد الكربون، والحماض.

Treatment Protocol

EN: Immediate management initiated: 1. Penile block with local anesthesia. 2. Aspiration of stagnant, dark blood from the corpora cavernosa. 3. Intracavernosal irrigation with normal saline. 4. Intracavernosal injection of sympathomimetic agent (e.g., Phenylephrine) titrated to effect. If refractory, consider distal shunting procedure (e.g., Winter, Ebbehoj, or Al-Ghorab shunt). AR: تم البدء بالإجراءات العلاجية الفورية: 1. تخدير موضعي للقضيب. 2. سحب الدم الراكد والداكن من الجسمين الكهفيين. 3. غسل الأجسام الكهفية بمحلول ملحي طبيعي. 4. حقن مادة محاكية للجهاز الودي (مثل فينيل إفرين) داخل الجسم الكهفي مع معايرة الجرعة حسب الاستجابة. في حال عدم الاستجابة، يتم النظر في إجراء تحويلة جراحية بعيدة (مثل تحويلة وينتر، أو إيبهوج، أو الغراب).

Patient Education

EN: Ischemic priapism is a urologic emergency. Delay in treatment significantly increases the risk of permanent erectile dysfunction and fibrosis. Please monitor for signs of infection, worsening pain, or recurrence. Avoid all PDE5 inhibitors and intracavernosal injections until cleared by a urologist. Seek immediate emergency care if symptoms return. AR: القساح الإقفاري (نقص التروية) هو حالة طارئة في المسالك البولية. التأخر في العلاج يزيد بشكل كبير من خطر الإصابة بضعف الانتصاب الدائم والتليف. يرجى مراقبة أي علامات للعدوى، أو زيادة في الألم، أو تكرار الحالة. يجب تجنب جميع مثبطات إنزيم فوسفودايستريز-5 والحقن داخل الجسم الكهفي حتى يتم السماح بذلك من قبل طبيب المسالك البولية. توجه فوراً للطوارئ في حال عودة الأعراض.

Systemic & Specialized Examinations

Cardiovascular

EN: S1, S2 present. No murmurs. Normal rate and rhythm. AR: صوتا القلب الأول والثاني طبيعيان. لا توجد نفخات.

Respiratory

EN: Lungs clear to auscultation bilaterally. No wheezes or crackles. AR: الرئتان صافيتان عند التسمع. لا يوجد أزيز أو كراكر.

Gastrointestinal

EN: Normal. AR: طبيعي.

Neurological

EN: Alert, oriented x3. Normal sacral reflexes (bulbocavernosus intact). AR: واعي ومدرك. المنعكسات العجزية طبيعية.

Dermatological

EN: Unremarkable or not routinely indicated for this specific urological/andrological pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض البولي أو الذكوري.

Psychiatric

EN: Unremarkable or not routinely indicated for this specific urological/andrological pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض البولي أو الذكوري.

OB/GYN

EN: Unremarkable or not routinely indicated for this specific urological/andrological pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض البولي أو الذكوري.

Ophthalmic

EN: Unremarkable or not routinely indicated for this specific urological/andrological pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض البولي أو الذكوري.

Dental

EN: Unremarkable or not routinely indicated for this specific urological/andrological pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض البولي أو الذكوري.

Orthopedic & Trauma Assessments

Mechanism of Injury

EN: Unremarkable or not routinely indicated for this specific urological/andrological pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض البولي أو الذكوري.

Gait & Posture

EN: Unremarkable or not routinely indicated for this specific urological/andrological pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض البولي أو الذكوري.

Range of Motion

EN: Unremarkable or not routinely indicated for this specific urological/andrological pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض البولي أو الذكوري.

Local Examination

EN: Unremarkable or not routinely indicated for this specific urological/andrological pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض البولي أو الذكوري.

Special Tests

EN: Unremarkable or not routinely indicated for this specific urological/andrological pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض البولي أو الذكوري.

Motor Power

EN: Unremarkable or not routinely indicated for this specific urological/andrological pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض البولي أو الذكوري.

Sensory Profile

EN: Unremarkable or not routinely indicated for this specific urological/andrological pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض البولي أو الذكوري.

Reflexes

EN: Unremarkable or not routinely indicated for this specific urological/andrological pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض البولي أو الذكوري.

Peripheral Pulses

EN: Unremarkable or not routinely indicated for this specific urological/andrological pathology. AR: طبيعي أو غير مطلوب روتينياً لهذا المرض البولي أو الذكوري.

1. Executive Overview: Understanding Ischemic (Low-Flow) Priapism

Ischemic (Low-Flow) Priapism is a persistent, painful penile erection that continues for more than four hours and occurs in the absence of sexual stimulation. Unlike "high-flow" or non-ischemic priapism, which is typically caused by trauma, ischemic priapism is a true urological emergency characterized by the failure of venous outflow from the corpora cavernosa.

In this condition, the blood within the penis becomes stagnant and deoxygenated (hypoxic), leading to a buildup of metabolic waste products and a decrease in pH (acidosis). This environment is toxic to the smooth muscle cells of the cavernosa. If left untreated, the oxygen-deprived tissue undergoes irreversible changes, including edema, fibrosis, and eventual necrosis. As a clinical specialist, I emphasize that the "four-hour rule" is the gold standard for clinical intervention; prolonged ischemia beyond 24–48 hours almost invariably results in permanent erectile dysfunction (ED).

ICD-10 Code: N48.3 (Priapism).

2. Pathophysiology, Etiology, and Risk Factors

The Pathophysiology of Stasis

The erectile mechanism relies on the relaxation of the smooth muscles in the corpora cavernosa, allowing arterial inflow to exceed venous outflow. In ischemic priapism, this mechanism is disrupted. The venous drainage is obstructed, trapping blood inside the cavernosa. As the trapped blood loses its oxygen content, the tissue transitions from a state of hypoxia to severe ischemia. This leads to:
* Intracavernosal Acidosis: A drop in pH levels below 7.0.
* Hypercapnia: A massive increase in carbon dioxide levels.
* Myocyte Damage: The smooth muscle cells undergo structural degradation and are eventually replaced by fibrous tissue (collagen deposition), which permanently prevents future erections.

Etiology and Common Triggers

Ischemic priapism is frequently associated with systemic conditions or pharmacological agents that alter the autonomic nervous system or blood rheology.

Category Primary Causes
Hematologic Sickle cell disease (most common in children), leukemia, thalassemia.
Pharmacological Phosphodiesterase type 5 (PDE5) inhibitors, intracavernosal injections (papaverine, alprostadil), antipsychotics (risperidone, olanzapine).
Neurological Spinal cord injuries, autonomic neuropathy.
Metabolic TPN (Total Parenteral Nutrition) complications, metabolic disorders.
Idiopathic Approximately 20–30% of cases have no identifiable underlying cause.

3. Clinical Presentation: Signs and Symptoms

The clinical presentation of ischemic priapism is distinctive and requires immediate medical attention. Patients typically present with:

  • Rigidity: The corpora cavernosa are rigid and tender to the touch.
  • Glans Sparing: A key clinical hallmark is that the glans penis (the head) and the corpus spongiosum (the underside of the penis) are usually soft and flaccid, as they are not involved in the ischemic process.
  • Pain: Unlike the pleasurable sensation of a normal erection, ischemic priapism is characterized by progressive, severe pain due to the lack of oxygen and the resulting acidosis.
  • Duration: The patient will report an erection lasting beyond four hours, often accompanied by significant psychological distress.

4. Standard Diagnostic Evaluation & Workup

A rapid, systematic diagnostic approach is essential to preserve future sexual function.

Physical Examination

The physician will palpate the penis to confirm the rigidity of the corpora cavernosa versus the flaccidity of the glans. A digital rectal exam or abdominal exam may be performed to rule out underlying malignancy or trauma.

Intracavernosal Blood Gas (ICBG) Analysis

This is the gold standard for diagnosis. A small-gauge needle is used to aspirate blood from the corpora cavernosa.
* Ischemic (Low-Flow): Dark, black blood; pH <7.25; pO2 <30 mmHg; pCO2 >60 mmHg.
* Non-Ischemic (High-Flow): Bright red (arterial) blood; pH and gas levels similar to systemic arterial blood.

Diagnostic Imaging

  • Penile Doppler Ultrasound: Used to assess blood flow. In ischemic cases, it will show absent or minimal cavernous artery flow.
  • Penile Arteriography: Reserved for cases where high-flow etiology is suspected or if there is a history of perineal trauma.
  • Laboratory Assays: Complete Blood Count (CBC) to check for sickle cell trait or leukemia, and toxicology screening if drug-induced priapism is suspected.

5. Therapeutic Interventions

Treatment follows a stepwise approach, moving from minimally invasive to surgical measures.

Step 1: Conservative Management & Aspiration

Initial management involves the aspiration of stagnant, deoxygenated blood from the corpora cavernosa. This is often performed under local anesthesia. By removing the trapped blood, the intra-cavernosal pressure drops, allowing fresh, oxygenated blood to re-enter.

Step 2: Intracavernosal Pharmacotherapy

Following aspiration, sympathomimetic agents (most commonly Phenylephrine) are diluted and injected directly into the corpora. Phenylephrine acts on alpha-adrenergic receptors to cause constriction of the smooth muscles, effectively closing the arterial inflow and opening the venous outflow channels.

Step 3: Surgical Shunting

If aspiration and pharmacotherapy fail, surgical shunting is required to create a bypass for the blood to flow out of the rigid corpora cavernosa into the venous system.
* Winter Shunt: A distal shunt created by excising a core of the glans.
* Al-Ghorab Shunt: A more extensive distal shunt.
* Quackles Shunt: A proximal, spongiosum-cavernosum shunt.

Step 4: Penile Prosthesis

In cases where the priapism has lasted for more than 48–72 hours, the tissue is often already necrotic. In these instances, immediate or delayed implantation of an inflatable penile prosthesis may be discussed to manage the inevitable permanent erectile dysfunction.

6. Frequently Asked Questions (FAQ)

1. Is ischemic priapism a medical emergency?
Yes. It is a time-sensitive emergency. Any erection lasting longer than four hours requires immediate evaluation in an emergency department.

2. Can I wait until morning to see a doctor?
No. Delaying treatment significantly increases the risk of permanent erectile dysfunction and tissue scarring.

3. What is the difference between ischemic and non-ischemic priapism?
Ischemic priapism is painful, rigid, and caused by trapped, oxygen-depleted blood. Non-ischemic priapism is typically painless, not fully rigid, and caused by an unregulated arterial inflow.

4. Will I be able to have an erection after treatment?
If treated within the first 4–12 hours, the prognosis for preserving erectile function is high. Delays beyond 24 hours significantly reduce the likelihood of natural recovery.

5. How is the diagnosis confirmed?
The definitive test is the Intracavernosal Blood Gas (ICBG) analysis, which differentiates ischemic from non-ischemic blood.

6. Does sickle cell disease cause priapism?
Yes. Sickle cell disease is a major risk factor for ischemic priapism due to the obstruction of blood flow by "sickled" red blood cells.

7. Are there long-term complications?
The most common complication is permanent erectile dysfunction due to fibrosis and scarring of the cavernous smooth muscle.

8. Can medications cause this condition?
Yes. Certain medications, including PDE5 inhibitors (like Viagra or Cialis) and some antipsychotics, are known triggers.

9. Is surgery always necessary?
Not always. Many cases are resolved through aspiration and intracavernosal injection of phenylephrine. Surgery is reserved for refractory cases.

10. What should I do if my erection is painful?
Go to the nearest emergency department immediately. Do not attempt home remedies, as they are ineffective and delay necessary medical care.

Disclaimer: This guide is for educational purposes and does not constitute medical advice. If you suspect you are experiencing priapism, seek immediate emergency medical care.

Treatment & Management Options

Share this guide: